Delivery Order SPE2DB22D3004-SPE2DB25FQD74

Award Date 4/3/25
Potential Completion Date 4/24/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Somatuline Depot 120 mg/0.5 ml medication. The contract has a ceiling value of $7,903.74 and a period of performance through May 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,903.74 contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a prescription medication. The order has a completion date of May 16, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Somatuline Depot 120 mg/0.5 mL. The contract has a firm fixed price of $5,792.82 and a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,951.86 contract is for the delivery of Somatuline Depot 120 mg/0.5 ml medication, with a period of performance through May 21, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order, valued at $11,585.64, is for the supply of Somatuline Depot 120 mg/0.5 ml drug products to be delivered by February 23, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
The U.S. Department of Defense (DoD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceuticals. The contract, valued at $2,896.41, has an ultimate completion date of April 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary...
The U.S. government awarded a delivery order contract worth $3,951.86 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML. The contract has a firm fixed price and is funded by the Defense Logistics Agency, a defense agency. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the Defense Logistics Agency Troop Support Medical, which provides a...
This is a $3,951.86 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the medical product "SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML" and has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a ceiling value of $3,951.86. The contract is a firm fixed price, delivery order type, with an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product, with a ceiling value of $3,951.86 and a period of performance through April 14, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQD74
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for 4,567,795,428 units of the drug Somatuline Depot 120 mg/0.5 ml, with a ceiling value of $3,951.86. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. There is no set-aside designation for this award. AmerisourceBergen, as the prime contractor, will be responsible for providing the specified pharmaceutical product to support military healthcare programs and other federal beneficiaries through this DLA contract vehicle.

Generated 7/3/25, 3:08 PM